Can Fite BioPharma prevailing Real Value cannot be determined due to lack of data. The current price of Can Fite BioPharma is S203.9. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Macroaxis approximates value of Can Fite BioPharma from analyzing the firm fundamentals such as Return On Equity of
(99.52)%, Current Valuation of 89.41M and Profit Margin of (133.93)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
|Horizon||30 Days Login to change|
Can Fite BioPharma Ltd is rated below average in beta category among related companies. It is rated below average in price to earning category among related companies .
|Price to Earning ( times )|
Can Fite is Unknown risk asset. Calculation of real value of Can Fite BioPharma is based on 2 months time horizon. Increasing Can Fite BioPharma time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.